Desktop Site
|
26 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Watch List
Get Quote
*
Notices
|
S&P
BSE SENSEX
73,730.16
-609.28
-0.82 %
Corporate Announcement
Security Code
506820
Company
ASTRAZENECA PHARMA INDIA LTD.
Exchange Received Time
26/03/2024 18:56:51
Exchange Disseminated Time
26/03/2024 18:56:51
Time Taken
00:00:00
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 |
3/26/2024 6:56:51 PM
This is to inform that AstraZeneca Pharma India Limited has received permission to import for sale and distribution of Trastuzumab deruxtecan lyophilized powder for concentrate for solution for infusion 100mg (Enhertu) from Central Drugs Standard Control Organisation, Directorate General of Health Services, Government of India for the attached additional indications.
Attachment
<< Back
Recently Viewed